Increased sensitivity of T lymphocytes to tumor necrosis factor receptor 1 (TNFR1)- and TNFR2-mediated apoptosis in HIV infection: Relation to expression of Bcl-2 and active caspase-8 and caspase-3

Blood

Volumn 99, Issue 5, 2002, Pages 1666-1675

  De Oliveira Pinto, Luzia Maria ^a,b   Garcia, Sylvie ^a,b   Lecoeur, Hervé ^a,b   Rapp, Christophe ^a,b   Gougeon, Marie Lise ^a,b  

^a INSTITUT PASTEUR   (France)

^b SERVICE D ENDOCRINOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CASPASE 3; CASPASE 8; CD4 ANTIGEN; CD8 ANTIGEN; DIDANOSINE; LAMIVUDINE; PROTEIN BCL 2; STAVUDINE; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; ZIDOVUDINE;

ADULT; APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRUS INFECTION; VIRUS LOAD;

EID: 0036493726     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.5.1666     Document Type: Article

References (49)

1. HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy
2. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes
3. + cells
4. + T cells from human immunodeficiency virus-infected asymptomatic individuals
5. Programmed cell death in AIDS-related HIV and SIV infections
6. Apoptosis in AIDS
7. + cell depletion in HIV disease
8. Programmed cell death in peripheral lymphocytes from HIV-infected persons: Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression
9. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden
10. + T lymphocytes during HIV infection
11. + patients
12. CD95's deadly mission in the immune system
13. Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children, Blood
14. Overexpression of Fas antigen on T cells in advanced HIV infection: Differential ligation constantly induces apoptosis
15. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals
16. Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS. Molecular control and effect of highly active anti-retroviral therapy
17. Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype
18. + lymphocyte depletion and human immunodeficiency virus replication
19. + T cells in vitro and in vivo: Association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid
20. + T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor
21. Potential deleterious effect of anti-viral cytotoxic lymphocytes through the CD95 (Fas/APO-1)-mediated pathway during chronic HIV infection
22. Tumor necrosis factor alpha and soluble tumor necrosis factor receptors in individuals with immunodeficiency virus infection
23. + T cells is mediated by macrophages through interaction of HIV gp 120 with chemokine receptor CXCR4
24. Apoptosis by death factor
25. Death receptors: Signaling and modulation
26. Regulated commitment of TNF receptor signaling: A molecular switch for death or activation
27. L on activated T cells and can be prevented by CD28 costimulation
28. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: A role for TNF-R1 activation by endogenous membrane-anchored TNF
29. Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods
30. A cytofluorometric method for the simultaneous detection of both intracellular and surface antigens on apoptotic peripheral lymphocytes
31. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies
32. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis
33. Proteases to die for
34. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells
35. Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals. Correlation with its ability to increase Bcl-2 expression
36. Interleukin-1-beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection-TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection
37. The role of interleukin-converting enzyme in Fas-mediated apoptosis in HIV-1 infection
38. A cysteine protease inhibitor prevents activation-induced T-cell apoptosis and death of peripheral blood cells from human immunodeficiency virus-infected individuals by inhibiting upregulation of Fas ligand
39. Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8
40. HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells
41. Apoptosis enhancement by the HIV-1 Nef protein
42. Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation
43. Diminished spontaneous apoptosis in lymphocytes from human immunodeficiency virus-infected long-term nonprogressors
44. Caspase activation is required for T cell proliferation
45. The inhibition of pro-apoptotic ICE-like proteases enhances HIV replication
46. CD8 naive T cell counts decrease progressively in HIV-infected adults
47. Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: Correlation with HIV-1 RNA and the clinical outcome
48. Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: Low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load
49. Alteration of tumor necrosis factor-α T-cell homeostasis following potent antiretroviral therapy: Contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome